Cytoprotective activity of amla (Emblica officinalis) against chromium (VI) induced oxidative injury in murine macrophages

Phytotherapy Research

Volumn 17, Issue 4, 2003, Pages 430-433

  Sai Ram, M ^a   Neetu, D ^a   Deepti, P ^a   Vandana, M ^a   Ilavazhagan, G ^a   Kumar, Devendra ^a   Seivamurthy, W ^a  

^a DEFENCE INSTITUTE OF PHYSIOLOGY AND ALLIED SCIENCES   (India)

Author keywords

Amla; Chromium VI; Cytoprotection; Emblica officinalis; Immunomodulation

Indexed keywords

CHROMIUM; EMBLICA OFFICINALIS EXTRACT; FREE RADICAL; GAMMA INTERFERON; GLUTATHIONE; GLUTATHIONE PEROXIDASE; IMMUNOMODULATING AGENT;

ANIMAL CELL; ARTICLE; CELL PROTECTION; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EMBLICA OFFICINALIS; ENZYME ACTIVITY; IMMUNOMODULATION; MACROPHAGE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PHAGOCYTOSIS;

ANIMALS; CHROMIUM; IMMUNOSUPPRESSIVE AGENTS; INTERFERON TYPE II; IONS; MACROPHAGES; MICE; PHAGOCYTOSIS; PHYLLANTHUS EMBLICA; PHYTOTHERAPY; PLANT EXTRACTS; PROTECTIVE AGENTS;

AMLA; EMBLICA; MURINAE; PHYLLANTHUS EMBLICA;

EID: 0037883538     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ptr.1157     Document Type: Article

References (29)

1. Asmawi MZ, Kankaanranta H, Moilanen E, Vapaataslo H. 1993. Anti-inflammatory activities of Emblica officinalis Gaertn leaf extracts. J Pharm Pharmacol 45: 581-584.
2. Bandopadhyay SK, Pakrashi SC, Pakrashi A. 2000. The role of antioxidant activity of Phyllanthus emblica fruits on prevention from iodomethacin induced gastric ulcer. J Ethnopharmacol 70: 171-176.
3. Bejma J, Ramires P, Ji LL. 2000. Free radical generation and oxidative stress with ageing and exercise: differential effects in the myocardium and liver. Acta Physiol Scand 169: 343-351.
4. Bhattacharya SK, Bhattacharya A, Chakrabarthy A. 2000. Adaptogenic activity of Siotone, a polyherbal formulation of Ayurvedic rasayanas. Indran J Exp Biol 38: 119-128.
5. Biswas S, Talukdar G, Sharma A. 1999. Protection against cytotoxic effect of arsenic by dietary supplementation with crude extract of Emblica officinalis fruit. Phytother Res 13: 513-516.
6. Blaheta RA, Franz M, Auth MKH, Wenisch HJC, Markus BH. 1991. Rapid non-radioactive fluorescence assay for the measurement of cell number and proliferation. J Immunol Meth 142: 199-206.
7. Burchill BR, Oliver JM, Pearson CB, Leinbach ED. 1978. Microtubule dynamics and glutathione metabolism in phagocytising human polymorphonuclear leukocytes. J Cell Biol 76: 439-447.
8. Cathcart R, Schwiers E, Ames BN. 1983. Detection of picomole levels of hydroperoxides using fluorescent dichlorofluorescein assay. Anal Biochem 134: 111-116.
9. Christensen MM, Ernst E, Ellermann-Eriksen S. 1992. Cytotoxic effects of chromium (VI) in cultured marine macrophages. Arch Toxicol 66: 347-353.
10. Dhir H, Aggarwak K, Sharma A, Talukdar G. 1991. Modifying role of Phyllanthus emblica and ascorbic acid against nickel clastogenicity in mice. Cancer Lett 59: 9-18.
11. Dhir H, Roy AK, Sharma A. 1993. Relative efficiency of Phyllanthus emblica fruit extract and ascorbic acid in modifying lead and aluminium induced-sister-chromatid - exchanges in mouse bone marrow. Env Mol Mut 21: 229-236.
12. El-Mekkawy S, Meselhy MR, Kusumoto IT, Kadota S, Hattori M, Namba T. 1995. Inhibitory effects of Egyptian folk medicines on human immunodeficiency virus (HIV) reverse transcriptase. Chem Pharmocol Bull 43: 641-648.
13. Ghosal S, Tripathi VK, Chauhan S. 1996. Active constituents of Emblica officinalis: part-1- the chemistry, and anti-oxidant effects of two hydrolysable tannins, emblicanin A and B. Indran J Chem 35B: 941-948.
14. Halliwell B. 1996. Anti-oxidants in human health and disease. Ann Rev Nutr 16: 33-50.
15. Hollan S. 1995. Free radicals in health and disease. Haematology 26: 177-189.
16. Jose JK, Kuttan R. 2000. Hepatoprotective activity of Emblica officinalis and Chyanaprash. J Ethnopharmacol 72: 135-140.
17. Jose JK, Kuttan G, Kuttan R. 2001. Antitumour activity of Emblica officinalis. J Ethnopharmacol 75: 65-69.
18. Kapoor LD. 1990. Handbook of Ayurvedic Medicinal Plants. CRC Press: Boca Raton.
19. Kendler BS. 1995. Free radicals in health and disease: implications for primary health care providers. Nurse Pract 20: 36-43.
20. Khangarot BS, Rathore RS, Tripathi DM. 1999. Effects of chromium on humoral and cell-mediated responses and host resistance of disease in a fresh water catfish, Saccobranchus fossilis (Bloch). Ecotoxicol Environ Saf 43: 11-20.
21. Langard S. 1990. One hundred years of chromium and cancer: A review of epidemiological evidence and selected case reports. Am J Ind Med 17: 189-215.
22. Meydani NM, Wu D, Santos MS, Hayek MG. 1995. Antioxidants and immune response in aged persons: overview of present evidence. Am J Clin Nutr 62: 1462S-1476S.
23. Rege NN, Thatte UM, Dahanukar SA. 1999. Adaptogenic properties of six rasayana herbs used in Ayurvedic medicine. Phytother Res. 13: 275-291.
24. Sai Ram M, Ilavazhagan G, Sharma SK et al., 2000. Anti-microbial activity of a new vaginal contraceptive NIM-76 from neem oil (Azadirachta indica). J Ethnopharmacol 71: 377-382.
25. Sali Ram M, Sharma SK, Ilavazhagan G, Devendra Kumar Selvamurthy W. 1997. Immunomodulatory properties of NIM-76, a volatile fraction from neem oil. J Ethnopharmacol 55: 133-139.
26. Scartezzini P, Speroni E. 2000. Review on some plants of Indian traditional medicine with anti-oxidant activity. J Ethnopharmacol 71: 23-43.
27. Sharma N, Trikha P, Athar M, Raisuddin S. 2000. In-vitro inhibition of carcinogen - induced mutagenicity by Cassia occidentalis and Emblica officinalis. Drug Chem Toxicol 23: 477-484.
28. Suresh K, Vasudevan DM. 1994. Augmentation of murine natural killer cell and antibody dependent cellular cytotoxicity activities by Phyllanthus emblica, a new immunomodulatory. J Ethnopharmacol 44: 55-60.
29. Yadav SK. 1987. Protection against radiation induced chromosome damage by Emblica officinalis fruit extract. Caryol 40: 261-265.